logo
Science Portal
Copyright © Médecins Sans Frontières
v2.1.5569.produseast1
About MSF Science Portal
About
Contact Us
Frequently Asked Questions (FAQs)
Privacy Policy
Terms of Use
Copyright © Médecins Sans Frontières
v2.1.5569.produseast1
Showing 1 - 3 of 3 Items
Showing 1 - 3 of 3 Items
Sort By: Relevance
  • Newest to oldest
  • Oldest to newest
  • Relevance
Journal Article
|
Letter

Legislation governing the US incentive scheme for neglected diseases needs to be amended, urges MSF

Reid J, Potet J, Athersuch K, Grovestock M, Sanjuan J
2014-09-30 • British Medical Journal (BMJ)
2014-09-30 • British Medical Journal (BMJ)
Journal Article
|
Pre-Print

MSF Access Campaign drug-resistant tuberculosis research and development case study May 2020

Cox V, Perrin C, Athersuch K, Martin M M, Alsalhani A
2020-06-01 • OSF Preprints
2020-06-01 • OSF Preprints
Two novel drugs, bedaquiline and delamanid, have recently become available to treat drug resistant tuberculosis (DR-TB) after many decades of little innovation in the field of DR-TB trea...
Journal Article
|
Commentary

Recently developed drugs for the treatment of drug-resistant tuberculosis: a research and development case study

Perrin C, Athersuch K, Elder G, Martin M, Alsalhani A
2022-04-19 • BMJ Global Health
2022-04-19 • BMJ Global Health
Two drugs with novel mechanisms of action, the diarylquinoline bedaquiline and the nitroimidazole delamanid—as well as pretomanid from the same class of drugs as delamanid—have recently ...